open access

Vol 11, No 3 (2017)
Review paper
Published online: 2017-12-21
Get Citation

The place of cannabinoids in the treatment of pain

Jarosław Woroń, Jan Dobrogowski
Medycyna Paliatywna w Praktyce 2017;11(3):96-101.

open access

Vol 11, No 3 (2017)
Review articles
Published online: 2017-12-21

Abstract

Cannabinoids represent another therapeutic option in patients with pain. Their legal availability for Polish patients causes acute pain doctors try to gather the most up-to-date information on the location of these drugs in the treatment of pain. The paper fulfills these expectations.

Abstract

Cannabinoids represent another therapeutic option in patients with pain. Their legal availability for Polish patients causes acute pain doctors try to gather the most up-to-date information on the location of these drugs in the treatment of pain. The paper fulfills these expectations.
Get Citation

Keywords

cannabinoids, pain, treatment

About this article
Title

The place of cannabinoids in the treatment of pain

Journal

Palliative Medicine in Practice

Issue

Vol 11, No 3 (2017)

Article type

Review paper

Pages

96-101

Published online

2017-12-21

Bibliographic record

Medycyna Paliatywna w Praktyce 2017;11(3):96-101.

Keywords

cannabinoids
pain
treatment

Authors

Jarosław Woroń
Jan Dobrogowski

References (13)
  1. Parker L. Cannabinoids and the Brain. The MIT Press. 2017.
  2. Maida V, Daeninck PJ. A user's guide to cannabinoid therapies in oncology. Curr Oncol. 2016; 23(6): 398–406.
  3. Schrot RJ, Hubbard JR. Cannabinoids: Medical implications. Ann Med. 2016; 48(3): 128–141.
  4. Young RJ, Nguyen M, Nelson E. Pain Medicine Springer, Switzerland 2017.
  5. Carroll CB, Bain PG, Teare L, et al. Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study. Neurology. 2004; 63(7): 1245–1250.
  6. Gancher ST. The Unified Parkinson’s Disease Rating Scale. Portland, OR: Demos Medical Publishing 2002.
  7. Sieradzan KA, Fox SH, Hill M, et al. Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology. 2001; 57(11): 2108–2111.
  8. Müller-Vahl KR, Schneider U, Koblenz A, et al. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Pharmacopsychiatry. 2002; 35(2): 57–61.
  9. Müller-Vahl KR, Schneider U, Prevedel H, et al. Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J Clin Psychiatry. 2003; 64(4): 459–465.
  10. Koppel BS, Brust JCM, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014; 82(17): 1556–1563.
  11. Ko GD, Bober SL, Mindra S, et al. Medical cannabis - the Canadian perspective. J Pain Res. 2016; 9: 735–744.
  12. Abrams D. Integrating Cannabis Into Clinical Care. Current Oncology . 2016; Suppl 2: 23.
  13. Kramer JL. Medical marijuana for cancer. CA Cancer J Clin. 2015; 65(2): 109–122.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Medycyna Paliatywna w Praktyce dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl